Axonal dysfunction and disability in a relapse of multiple sclerosis: Longitudinal study of a patient

Neurology

Volumn 49, Issue 4, 1997, Pages 1138-1141

  De Stefano, N ^a,b   Matthews, P M ^b   Narayanan, S ^c   Francis, G S ^c   Antel, J P ^a   Arnold, D L ^d  

^a Department of Neurology and Neurosurgery ^*  (United Kingdom)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITY OF SIENA   (Italy)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

N ACETYLASPARTIC ACID;

ADULT; ARTICLE; BRAIN SIZE; CASE REPORT; DISABILITY; FOLLOW UP; HUMAN; MALE; MULTIPLE SCLEROSIS; NERVE FIBER DEGENERATION; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RELAPSE; REMISSION; WHITE MATTER;

EID: 0030709270     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.49.4.1138     Document Type: Article

References (12)

1. Miller DH, Albert PS, Barkhof F, et al. Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. US National MS Society Task Force. Ann Neurol 1996;39:6-16.
2. Husted CA, Goodin DS, Hugg JW, et al. Biochemical alterations in multiple sclerosis lesions and normal-appearing white matter detected by in vivo 3 IP and 1H spectroscopic imaging. Ann Neurol 1994;36:157-165.
3. De Stefano N, Matthews PM, Antel JP, Preul M, Francis G, Arnold DL. Chemical-pathology of acute demyelinating lesion and its correlation with disability. Ann Neurol 1995;38:901-909.
4. Filippi M, Campi A, Colombo B, et al. A spinal cord MRI study of benign and secondary progressive multiple sclerosis. J Neurol 1996;243:502-505.
5. Arnold DL, Riess GT, Matthews PM, et al. Use of proton magnetic resonance spectroscopy for monitoring disease progression in multiple sclerosis. Ann Neurol 1994;36:76-82.
6. Pan JW, Hetherington HP, Vaughan JT, et al. Evaluation of multiple sclerosis by H-l spectroscopic imaging at 4.1 T. Magn Reson Med 1996;36:72-77.
7. Rasminsky M. Pathophysiology of demyelination [review]. Ann NY Acad Sei 1984;436:68-85.
8. Davie CA, Barker GJ, Webb S, et al. Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss. Brain 1995;118:1583-1592.
9. Brenner RE, Munro PM, Williams SC, et al. The proton NMR spectrum in acute EAE: the significance of the change in the Cho:Cr ratio. Magn Reson Med 1993;29:737-745.
10. Vion-Dury J, Nicoli F, Salvan AM, et al. Reversal of brain metabolic alterations with zidovudine detected by proton localised magnetic resonance spectroscopy [letter]. Lancet 1995; 345:60-61.
11. Moreau T, Coles A, Wing M, et al. Transient increase in symptoms associated with cytokine release in patients with multiple sclerosis. Brain 1996;119:225-237.
12. Koller H, Buchholz J, Siebler M, et al. Cerebrospinal fluid from multiple sclerosis patients inactivates neuronal NA+ current. Brain 1996;119:457-463.